Axogen, Inc. — Director's Dealing 2018

Oct 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-10-02

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-02	Common Stock	G	20000	—	Disposed	344761	Direct

Footnotes

F1: The shares of common stock for Dr. Gold include 212,761 shares held jointly by Dr. Gold and his wife and indirect ownership of 122,000 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. The transaction reflected on this Form 4 relates to the transfer of 20,000 indirect ownership shares held by Dr. Gold's spouse to MJKS, Ltd.